Axsome Therapeutics, Inc. (AXSM)
137.01
-4.68
(-3.30%)
USD |
NASDAQ |
Nov 16, 16:00
135.01
-2.00
(-1.46%)
After-Hours: 06:30
Axsome Therapeutics Max Drawdown (5Y) : 79.54% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 79.54% |
| September 30, 2026 | 79.54% |
| August 31, 2026 | 79.54% |
| July 31, 2026 | 81.26% |
| June 30, 2026 | 81.26% |
| May 31, 2026 | 81.26% |
| April 30, 2026 | 81.26% |
| March 31, 2026 | 81.26% |
| February 28, 2026 | 81.26% |
| January 31, 2026 | 81.26% |
| December 31, 2025 | 81.26% |
| November 30, 2025 | 81.26% |
| October 31, 2025 | 81.26% |
| September 30, 2025 | 81.26% |
| August 31, 2025 | 81.26% |
| July 31, 2025 | 81.26% |
| June 30, 2025 | 81.26% |
| May 31, 2025 | 81.26% |
| April 30, 2025 | 81.26% |
| March 31, 2025 | 81.26% |
| February 28, 2025 | 81.26% |
| January 31, 2025 | 81.26% |
| December 31, 2024 | 81.26% |
| November 30, 2024 | 81.26% |
| October 31, 2024 | 81.26% |
| Date | Value |
|---|---|
| September 30, 2024 | 81.26% |
| August 31, 2024 | 81.26% |
| July 31, 2024 | 81.26% |
| June 30, 2024 | 81.26% |
| May 31, 2024 | 81.26% |
| April 30, 2024 | 81.26% |
| March 31, 2024 | 81.26% |
| February 29, 2024 | 81.26% |
| January 31, 2024 | 81.26% |
| December 31, 2023 | 82.44% |
| November 30, 2023 | 86.65% |
| October 31, 2023 | 86.65% |
| September 30, 2023 | 86.65% |
| August 31, 2023 | 86.65% |
| July 31, 2023 | 86.65% |
| June 30, 2023 | 86.65% |
| May 31, 2023 | 86.65% |
| April 30, 2023 | 86.65% |
| March 31, 2023 | 86.65% |
| February 28, 2023 | 86.65% |
| January 31, 2023 | 86.65% |
| December 31, 2022 | 86.65% |
| November 30, 2022 | 86.65% |
| October 31, 2022 | 86.65% |
| September 30, 2022 | 86.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly & Co. | 34.47% |
| Filana Therapeutics, Inc. | 99.34% |
| CorMedix, Inc. | 84.47% |
| Eloxx Pharmaceuticals, Inc. | 100.0% |
| Breakthrough Chemistry, Inc. | 99.04% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 19.36 |
| Beta (5Y) | 0.8598 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 66.42% |
| Historical Sharpe Ratio (5Y) | 0.3977 |
| Historical Sortino (5Y) | 0.9113 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.00% |